Cargando…
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe X-linked neuromuscular childhood disorder that causes progressive muscle weakness and degeneration and results in functional decline, loss of ambulation and early death of young men due to cardiac or respiratory failure. Although the major ca...
Autores principales: | Łoboda, Agnieszka, Dulak, Józef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550322/ https://www.ncbi.nlm.nih.gov/pubmed/32691346 http://dx.doi.org/10.1007/s43440-020-00134-x |
Ejemplares similares
-
Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019) -
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
por: Kaziród, Katarzyna, et al.
Publicado: (2022) -
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
por: Mucha, Olga, et al.
Publicado: (2021) -
The multifaceted view of heart problem in Duchenne muscular dystrophy
por: Florczyk-Soluch, Urszula, et al.
Publicado: (2021) -
Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout
por: Mucha, Olga, et al.
Publicado: (2021)